Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Goldsmith

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.
Pharmacology|May 4, 2007
GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utilityPaul Goldsmith, Zoe Golder, Julia Hunt, et al.
Neuroimage|July 18, 2016
A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitorAkihiro Takano, Per Stenkrona, Vladimir Stepanov, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2008
Discovery of a novel indole series of EP1 receptor antagonists by scaffold hoppingAdrian Hall, Andy Billinton, Susan H Brown, et al.
World Journal of Surgery|April 25, 2026
Surgical Tray Set Rationalization at an Elective Surgical Hub in England: Methodology, Feasibility, Implementation and Impact on Financial Costs and Carbon EmissionsPrakriti Shrestha, Jane Roylance, Toli Onon, et al.
Journal of Cell Science|September 5, 2008
Chondroitin-4-sulfation negatively regulates axonal guidance and growthHang Wang, Yasuhiro Katagiri, Thomas E McCann, et al.
Nature Chemical Biology|April 9, 2008
Novel targets for Huntington's disease in an mTOR-independent autophagy pathwayAndrea Williams, Sovan Sarkar, Paul Cuddon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15Ronald Wolf, O M Zack Howard, Hui-Fang Dong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2024
Volenrelaxin (LY3540378) increases renal plasma flow: a randomized Phase 1 trialLai San Tham, Hiddo J L Heerspink, Xiaojun Wang, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.
Pharmacology|May 4, 2007
GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utilityPaul Goldsmith, Zoe Golder, Julia Hunt, et al.
Neuroimage|July 18, 2016
A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitorAkihiro Takano, Per Stenkrona, Vladimir Stepanov, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2008
Discovery of a novel indole series of EP1 receptor antagonists by scaffold hoppingAdrian Hall, Andy Billinton, Susan H Brown, et al.
World Journal of Surgery|April 25, 2026
Surgical Tray Set Rationalization at an Elective Surgical Hub in England: Methodology, Feasibility, Implementation and Impact on Financial Costs and Carbon EmissionsPrakriti Shrestha, Jane Roylance, Toli Onon, et al.
Journal of Cell Science|September 5, 2008
Chondroitin-4-sulfation negatively regulates axonal guidance and growthHang Wang, Yasuhiro Katagiri, Thomas E McCann, et al.
Nature Chemical Biology|April 9, 2008
Novel targets for Huntington's disease in an mTOR-independent autophagy pathwayAndrea Williams, Sovan Sarkar, Paul Cuddon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15Ronald Wolf, O M Zack Howard, Hui-Fang Dong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2024
Volenrelaxin (LY3540378) increases renal plasma flow: a randomized Phase 1 trialLai San Tham, Hiddo J L Heerspink, Xiaojun Wang, et al.
Pageof 11